Related Experiment Video

Updated: Jun 23, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

The common hyperlipoproteinemias: an understanding of disease mechanisms and their control

W R Fisher, D H Truitt

    Annals of Internal Medicine
    |October 1, 1976
    PubMed

    Insights

    This review examines low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) roles in cholesterol/triglyceride transport and cardiovascular disease. Understanding lipoprotein metabolism aids in tailoring therapies for hyperlipoproteinemias.

    Area of Science:

    • Cardiovascular Medicine
    • Metabolic Disorders
    • Lipid Metabolism

    Background:

    • Low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) are key transporters of cholesterol and triglycerides.
    • These lipoproteins are implicated as significant factors in the development of premature atherosclerotic cardiovascular disease.
    • Understanding their roles is crucial for managing dyslipidemias and preventing cardiovascular events.

    Purpose of the Study:

    • To review the functions of LDL and VLDL in lipid transport.
    • To describe clinical manifestations and metabolic variations in primary hyperlipoproteinemias.
    • To discuss therapeutic strategies for altering LDL and VLDL concentrations.

    Main Methods:

    • Literature review focusing on lipoprotein structure, metabolism, and disease.
    • Analysis of clinical presentations of hyperlipoproteinemias.
    • Discussion of factors influencing lipoprotein levels and therapeutic interventions.

    Main Results:

    • Detailed description of hyper-beta-lipoproteinemia, combined hyperlipoproteinemia, hyper-pre-beta-lipoproteinemia, and sporadic hyperlipoproteinemia.
    • Explanation of variations in lipoprotein structure and metabolism specific to these conditions.
    • Identification of lifestyle and pharmacological factors affecting LDL and VLDL levels.

    Conclusions:

    • Physiological understanding of lipoprotein metabolism enables targeted therapeutic interventions.
    • Specific therapies can effectively modify LDL and VLDL concentrations in hyperlipoproteinemias.
    • Management strategies should be tailored to the individual's specific lipoprotein disorder and contributing factors.

    More Related Videos

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

    Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

    Published on: January 28, 2021

    Assessing Whole-Body Lipid-Handling Capacity in Mice07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    Related Concept Videos

    Lipid-derived Compounds in the Human Body01:31

    Lipid-derived Compounds in the Human Body

    Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
    Fat-soluble Vitamins
    Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
    Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

    Lipid-Lowering Drugs: Statins and Miscellaneous Agents

    Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
    Overview of Lipid Metabolism01:24

    Overview of Lipid Metabolism

    Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
    Lipolysis: The Breakdown of Lipids:
    Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    Pharmacogenomics: Identification of New Drug Targets01:29

    Pharmacogenomics: Identification of New Drug Targets

    Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
    Atherosclerosis III: Management01:26

    Atherosclerosis III: Management

    Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...